Cuomo, workplace, harassment
Governor Andrew Cuomo signed a bill into law this week that will likely lead to an increase in workplace harassment and discrimination cases. Most notable, it removes the "severe or pervasive" requirement for harassment to be considered the company's responsibility, holding employers more accountable for their workers' conduct. (Photo: Pat Arnow via Flickr)

Cuomo Signs Bill that Expands Workplace Harassment and Discrimination Laws

Last month, New York Governor Andrew Cuomo was expected to sign a bill that would amend and strengthen existing workplace harassment and discrimination laws. This week, he delivered.

Related Story: New York State Expands Workplace Harassment Laws

The legislation, which Cuomo signed into law Aug. 12, has dozens of amendments to New York’s existing workplace harassment laws, but its most notable changes include removing the “severe or pervasive” wording, which set a requirement for the level of severity abusive conduct must have before a company can be held accountable. Additionally, the new law expands the definition of what a company can consider an “employee,” including independent contractors and other outside workers who serve an organization.

Cuomo had previously called the “severe or pervasive” standard “absurd,” and now, any conduct on the basis of age, race, sex and other, expanded categories that is beyond “petty slights and trivial inconveniences” can be considered workplace harassment for which the employer is responsible. The law now covers private employers, including small businesses that were exempt from the previous law, state and local governments, domestic workers and independent contractors.

In part, the action was spurred by testimonies of sexual harassment and retaliation against New York State Assembly members that came out earlier this year. The Sexual Harassment Working Group that seven former legislative employees founded pushed for the change.

The law also raises the statute of limitations in filing a claim with the Division of Human Rights from one to three years.

Additionally, it requires a thorough review of employers’ harassment and discrimination policies every four years.

And employers are going to want to tighten up their policies: The main defense an employer may have in a harassment of discrimination case — that the victim did not make a complaint to the employer — is now unusable. Even if an individual “did not make a complaint about the harassment to such employer, licensing agency, employment agency or labor organization” it “shall not be determinative” as to whether or not the employer be held liable, the law says.

Therefore, even if the harassment happens outside of business hours or over text, companies can still be held responsible, which has sparked controversy. Employers can expect an increase in harassment and discrimination cases as a result of the new legislation.

The law will take effect in three phases starting in two months.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….